CLOV
Price
$0.89
Change
-$0.04 (-4.30%)
Updated
May 17, 6:59 PM EST
80 days until earnings call
NEUE
Price
$6.08
Change
-$0.09 (-1.46%)
Updated
May 17, 6:59 PM EST
Ad is loading...

CLOV vs NEUE

Header iconCLOV vs NEUE Comparison
Open Charts CLOV vs NEUEBanner chart's image
Clover Health Investments
Price$0.89
Change-$0.04 (-4.30%)
Volume$5.21M
CapitalizationN/A
NeueHealth
Price$6.08
Change-$0.09 (-1.46%)
Volume$1.62K
CapitalizationN/A
View a ticker or compare two or three
CLOV vs NEUE Comparison Chart

Loading...

CLOVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NEUEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CLOV vs. NEUE commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a StrongBuy and NEUE is a StrongSell.

COMPARISON
Comparison
May 18, 2024
Stock price -- (CLOV: $0.89 vs. NEUE: $5.99)
Brand notoriety: CLOV and NEUE are both not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CLOV: 77% vs. NEUE: 53%
Market capitalization -- CLOV: $381.23M vs. NEUE: $52M
CLOV [@Managed Health Care] is valued at $381.23M. NEUE’s [@Managed Health Care] market capitalization is $52M. The market cap for tickers in the [@Managed Health Care] industry ranges from $451.47B to $0. The average market capitalization across the [@Managed Health Care] industry is $63.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 0 FA rating(s) are green whileNEUE’s FA Score has 0 green FA rating(s).

  • CLOV’s FA Score: 0 green, 5 red.
  • NEUE’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLOV and NEUE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 5 TA indicator(s) are bullish while NEUE’s TA Score has 3 bullish TA indicator(s).

  • CLOV’s TA Score: 5 bullish, 5 bearish.
  • NEUE’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both CLOV and NEUE are a good buy in the short-term.

Price Growth

CLOV (@Managed Health Care) experienced а +8.54% price change this week, while NEUE (@Managed Health Care) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was +0.32%. For the same industry, the average monthly price growth was +10.07%, and the average quarterly price growth was +20.79%.

Reported Earning Dates

CLOV is expected to report earnings on Aug 06, 2024.

NEUE is expected to report earnings on Aug 09, 2023.

Industries' Descriptions

@Managed Health Care (+0.32% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

SUMMARIES
A.I.dvisor published
a Summary for CLOV with price predictions.
OPEN
A.I.dvisor published
a Summary for NEUE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CLOV($381M) has a higher market cap than NEUE($52M). CLOV YTD gains are higher at: -6.522 vs. NEUE (-21.494).
CLOVNEUECLOV / NEUE
Capitalization381M52M733%
EBITDA-210.84MN/A-
Gain YTD-6.522-21.49430%
P/E RatioN/AN/A-
Revenue2.03BN/A-
Total Cash243MN/A-
Total Debt4.66MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CLOVNEUE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CLOVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NEUEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPVG9.400.24
+2.62%
TRIPLEPOINT VENTURE GROWTH BDC Corp
SM48.950.50
+1.03%
SM Energy Company
RACE422.302.73
+0.65%
Ferrari NV
TACT3.75N/A
N/A
TransAct Technologies
MORF29.23-3.22
-9.92%
Morphic Holding

CLOV and

Correlation & Price change

A.I.dvisor tells us that CLOV and OSCR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLOV and OSCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLOV
1D Price
Change %
CLOV100%
-4.70%
OSCR - CLOV
27%
Poorly correlated
+1.67%
CVS - CLOV
24%
Poorly correlated
+0.28%
NEUE - CLOV
24%
Poorly correlated
-2.12%
ELV - CLOV
24%
Poorly correlated
+0.70%
ALHC - CLOV
20%
Poorly correlated
+3.86%
More

NEUE and

Correlation & Price change

A.I.dvisor tells us that NEUE and CLOV have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NEUE and CLOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUE
1D Price
Change %
NEUE100%
-2.12%
CLOV - NEUE
24%
Poorly correlated
-4.70%
CVS - NEUE
21%
Poorly correlated
+0.28%
UNH - NEUE
21%
Poorly correlated
+0.64%
CI - NEUE
21%
Poorly correlated
-0.16%
OSCR - NEUE
21%
Poorly correlated
+1.67%
More